FDA
-
-
-
-
-
-
-
Bionomics Limited (BNOX) Initiates AFFIRM-1 Phase 3 Trial
-
-
-
-
-
-
-
Bionomics Provides a Review of 2023 and of 2024 Plans
-
-
-
-
-
-
-
Quarterly Activities and Cashflow Report
-
-
-
-
-
-
-
Quarterly Activities Report for June 2022
-
-
-
-
322,242 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

